• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Gentherm Announces Dr. Ken Washington as New Independent Director

    10/2/23 8:00:00 AM ET
    $AMZN
    $F
    $MCK
    $MDT
    Catalog/Specialty Distribution
    Consumer Discretionary
    Auto Manufacturing
    Industrials
    Get the next $AMZN alert in real time by email

    NORTHVILLE, Mich., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems, today announced that Dr. Ken Washington has been appointed to the Company's Board of Directors, effective October 2, 2023.

    Dr. Washington is the Senior Vice President, Chief Technology and Innovation Officer of Medtronic plc (NYSE:MDT), a global healthcare technology company that provides device-based medical therapies and services. He was appointed to this position in June 2023, and he leads innovation and the expansion of technology platforms across Medtronic's portfolio. Prior to joining Medtronic, Dr. Washington served as the Vice President of Software Engineering, Consumer Robotics for Amazon Lab126, a premier innovation hub and subsidiary of Amazon.com, Inc. (NASDAQ:AMZN). At Amazon Lab 126, Dr. Washington was responsible for all aspects of the profitability of Amazon's consumer robotics business unit. Before Amazon Lab 126, he held varying positions at Ford Motor Company (NYSE:F), including serving as Chief Technology Officer. At Ford, he led the worldwide research organization, oversaw the development and implementation of Ford's technology strategy and plans, oversaw the autonomous vehicle program, and played a key role in Ford's expansion into emerging mobility opportunities. Dr. Washington worked at Lockheed Martin Corporation as Vice President of the Advanced Technology Center and its first Chief Privacy Officer. Dr. Washington also served for approximately 21 years in various roles at Sandia National Laboratories, including as Chief Information Officer.

    Dr. Washington previously served as a member of the Board of Directors of McKesson Corporation (NYSE:MCK) from July 2019 to October 2021, including as a member of the Compliance and Finance Committees, as well as numerous private company boards and advisory boards of academic institutions.

    "We are pleased to welcome Ken to Gentherm's Board of Directors," said Ronald Hundzinski, Chair of the Board of Gentherm. "Ken brings years of experience in technology, research, and strategy across global automotive and medical organizations that will be a valuable asset to Gentherm's Board."

    "Ken's strong track record of leading technology development and execution makes him an ideal Board member to help drive innovation and strategy to strengthen shareholder value," said Phil Eyler, President and CEO of Gentherm. "I look forward to his insight and counsel and am excited for him to join as a new member of our Board of Directors."

    Dr. Washington earned his bachelor's, master's, and doctorate degrees in nuclear engineering from Texas A&M University.

    Investor Contact

    Yijing Brentano

    [email protected]

    248.308.1702

    Media Contact

    Melissa Fischer

    [email protected]

    248.289.9702

    About Gentherm

    Gentherm (NASDAQ:THRM) is the global market leader in innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems. Automotive products include variable temperature Climate Control Seats, heated automotive interior systems (including heated seats, steering wheels, armrests, and other components), battery performance solutions, cable systems, lumbar and massage comfort solutions, valve system technologies, and other electronic devices. Medical products include patient temperature management systems. The Company is also developing a number of new technologies and products that will help enable improvements to existing products and to create new product applications for existing and new markets. Gentherm has more than 14,000 employees in facilities in the United States, Germany, China, Czech Republic, Hungary, Japan, Malta, Mexico, North Macedonia, South Korea, United Kingdom, Ukraine, and Vietnam. For more information, go to www.gentherm.com.



    Primary Logo

    Get the next $AMZN alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMZN
    $F
    $MCK
    $MDT

    CompanyDatePrice TargetRatingAnalyst
    Ford Motor Company
    $F
    10/6/2025$12.00Underperform → Hold
    Jefferies
    Amazon.com Inc.
    $AMZN
    10/3/2025$240.00 → $275.00Buy
    Goldman
    Amazon.com Inc.
    $AMZN
    9/30/2025$300.00Outperform
    Mizuho
    Amazon.com Inc.
    $AMZN
    9/24/2025$280.00Equal Weight → Overweight
    Wells Fargo
    Amazon.com Inc.
    $AMZN
    9/16/2025$250.00 → $270.00Buy
    Truist
    Amazon.com Inc.
    $AMZN
    8/1/2025$260.00 → $280.00Overweight
    Cantor Fitzgerald
    Amazon.com Inc.
    $AMZN
    8/1/2025$225.00 → $260.00Positive
    Susquehanna
    Amazon.com Inc.
    $AMZN
    8/1/2025$230.00 → $265.00Buy
    DA Davidson
    More analyst ratings

    $AMZN
    $F
    $MCK
    $MDT
    SEC Filings

    View All

    Ford Motor Company filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - FORD MOTOR CO (0000037996) (Filer)

    10/1/25 9:45:41 AM ET
    $F
    Auto Manufacturing
    Industrials

    SEC Form 25-NSE filed by Medtronic plc.

    25-NSE - Medtronic plc (0001613103) (Subject)

    9/29/25 10:44:27 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form CERT filed by Medtronic plc.

    CERT - Medtronic plc (0001613103) (Filer)

    9/29/25 9:53:17 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $AMZN
    $F
    $MCK
    $MDT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Jellison William R bought $462,750 worth of Ordinary Shares (5,000 units at $92.55) (SEC Form 4)

    4 - Medtronic plc (0001613103) (Issuer)

    8/25/25 5:18:06 PM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Washington Kenneth E bought $47,702 worth of shares (1,700 units at $28.06), increasing direct ownership by 18% to 10,965 units (SEC Form 4)

    4 - Gentherm Inc (0000903129) (Issuer)

    5/13/25 4:10:38 PM ET
    $THRM
    Auto Parts:O.E.M.
    Consumer Discretionary

    Director Hundzinski Ronald T bought $133,350 worth of shares (5,000 units at $26.67), increasing direct ownership by 38% to 18,006 units (SEC Form 4)

    4 - Gentherm Inc (0000903129) (Issuer)

    5/12/25 4:06:43 PM ET
    $THRM
    Auto Parts:O.E.M.
    Consumer Discretionary

    $AMZN
    $F
    $MCK
    $MDT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Ford Motor upgraded by Jefferies with a new price target

    Jefferies upgraded Ford Motor from Underperform to Hold and set a new price target of $12.00

    10/6/25 8:20:43 AM ET
    $F
    Auto Manufacturing
    Industrials

    Goldman reiterated coverage on Amazon with a new price target

    Goldman reiterated coverage of Amazon with a rating of Buy and set a new price target of $275.00 from $240.00 previously

    10/3/25 8:14:34 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Mizuho initiated coverage on Amazon with a new price target

    Mizuho initiated coverage of Amazon with a rating of Outperform and set a new price target of $300.00

    9/30/25 8:42:19 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AMZN
    $F
    $MCK
    $MDT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 11, 2025 - FDA Roundup: March 11, 2025

    For Immediate Release: March 11, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA published a General Correspondence Letter issued to Mid-Link Technology Testing Co., Ltd. The FDA is vigilant in ensuring data submitted to the FDA can be relied upon to assess the effectiveness, safety, or risk of a device. The FDA has noted an incr

    3/13/25 3:14:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    November 14, 2023 - FDA Roundup: November 14, 2023

    For Immediate Release: November 14, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, the FDA updated the advisory for the Investigation of Elevated Lead Levels in Cinnamon Applesauce Pouches to include an expanded recall from WanaBana LLC to include Weis and Schnucks-brand cinnamon applesauce pouches. As of November 13, 2023, there

    11/14/23 3:26:18 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AMZN
    $F
    $MCK
    $MDT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: New insider Boler-Davis Alicia S claimed ownership of 185 shares (SEC Form 3)

    3/A - FORD MOTOR CO (0000037996) (Issuer)

    10/8/25 4:30:45 PM ET
    $F
    Auto Manufacturing
    Industrials

    New insider Boler-Davis Alicia S claimed ownership of 185 shares (SEC Form 3)

    3 - FORD MOTOR CO (0000037996) (Issuer)

    10/6/25 5:03:54 PM ET
    $F
    Auto Manufacturing
    Industrials

    CEO Worldwide Amazon Stores Herrington Douglas J sold $542,750 worth of shares (2,500 units at $217.10), decreasing direct ownership by 0.48% to 515,507 units (SEC Form 4)

    4 - AMAZON COM INC (0001018724) (Issuer)

    10/3/25 4:56:08 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AMZN
    $F
    $MCK
    $MDT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Medtronic BrainSense™ Adaptive Deep Brain Stimulation named a 2025 TIME Best Inventions

    TIME Best Inventions honors extraordinary innovations changing lives DUBLIN, Oct. 9, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that BrainSense™ Adaptive Deep Brain Stimulation (aDBS) – the world's first closed-loop DBS system for people with Parkinson's – has been recognized by TIME on its annual list of Best Inventions. There are over 10 million people living with Parkinson's disease globally,1 and while there is currently no cure, Medtronic deep brain stimulation (DBS) has been transforming the lives of people with Parkinson's and other neurological disorders for more than 30 years. Medtronic recently enhanced its Percept™ DBS

    10/9/25 10:10:00 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Orchestra BioMed to Showcase Transformative Potential of AVIM Therapy in Keynote Presentation on Hypertensive Heart Disease at Georgia Innovation Summit

    Presentation to provide comprehensive overview of AVIM Therapy clinical evidence demonstrating the potential to halt the progression of hypertensive heart diseaseOrchestra BioMed and Medtronic (NYSE:MDT) have a strategic collaboration to develop and commercialize AVIM Therapy for the treatment of uncontrolled hypertension in patients indicated for a pacemaker, an estimated global population of over 750,000 patients annuallyAVIM Therapy has received FDA Breakthrough Device Designation for the treatment of uncontrolled hypertension in patients with increased cardiovascular risk, an estimated U.S. population of over 7.7 million patients NEW HOPE, Pa., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Orches

    10/9/25 8:00:00 AM ET
    $MDT
    $OBIO
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Medicinal Chemicals and Botanical Products

    Gentherm Announces Date for 2025 Third Quarter News Release and Conference Call

    NOVI, Mich., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, will report its financial results for the third quarter 2025 on Thursday, October 23, 2025, and will host a conference call to discuss those results at 8 am (ET) that same day. Conference CallToll-free dial-in number: 1-877-407-4018International dial-in number: 1-201-689-8471Conference ID number: 13756525 WebcastA live webcast and one-year archived replay of the call can be accessed on the Events page of the Investor Relations section of Gentherm's website at www.gentherm.com. A telephonic replay will be available approximatel

    10/8/25 4:30:00 PM ET
    $THRM
    Auto Parts:O.E.M.
    Consumer Discretionary

    $AMZN
    $F
    $MCK
    $MDT
    Leadership Updates

    Live Leadership Updates

    View All

    ChargeScape and PSEG Long Island Partner to Enroll BMW and Ford Electric Vehicles in First-Ever Grid Reliability Program Participation

    HICKSVILLE, N.Y., July 22, 2025 (GLOBE NEWSWIRE) -- ChargeScape, a joint venture between BMW, Honda, Ford, and Nissan, today announced a partnership with PSEG Long Island to enroll electric vehicles (EVs) in the utility's Peak Load Reduction program, a first in the nine-year history of the utility's peak load reduction programs. Designed to alleviate strain on the power grid during summer months, the initiative will leverage ChargeScape's AI-powered technology platform and aims to intelligently integrate more than 4,000 BMW EV drivers and 2,200 Ford EV drivers into the power grid. Participating customers will receive financial incentives for helping to support grid stability and community

    7/22/25 7:00:00 AM ET
    $F
    Auto Manufacturing
    Industrials

    Medtronic announces appointment of MiniMed chief financial officer ahead of intended separation into standalone company

    GALWAY, Ireland, July 8, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the appointment of Chad Spooner as chief financial officer (CFO) of MiniMed, in advance of its intended separation into a standalone, public company. Effective July 14, 2025, Chad will be responsible for overseeing the Finance function for Medtronic Diabetes and supporting initiatives aimed at accelerating profitable growth and delivering shareholder value as it prepares to become fully independent.  Chad brings over 25 years of financial leadership experience across healthcare, consumer, and industrial sectors. Most recently, he served as CFO at BIC (BB:PA), a pu

    7/8/25 8:45:00 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Medtronic Board appoints Dr. Joon Lee as a new director

    GALWAY, Ireland, June 23, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that its Board of Directors appointed Dr. Joon Lee, CEO at Emory Healthcare, Inc., to the Board as an independent director, effective June 18, 2025. Dr. Lee will serve on the Science and Technology Committee and Compensation and Talent Committee of the Board. "We are thrilled to welcome Dr. Lee, a highly respected interventional cardiologist and healthcare executive, to Medtronic's Board of Directors," said Geoff Martha, chairman and chief executive officer. "Dr. Lee brings deep expertise as a clinical researcher, academic leader, and physician executive with dec

    6/23/25 4:15:00 PM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $AMZN
    $F
    $MCK
    $MDT
    Financials

    Live finance-specific insights

    View All

    Gentherm Announces Date for 2025 Third Quarter News Release and Conference Call

    NOVI, Mich., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, will report its financial results for the third quarter 2025 on Thursday, October 23, 2025, and will host a conference call to discuss those results at 8 am (ET) that same day. Conference CallToll-free dial-in number: 1-877-407-4018International dial-in number: 1-201-689-8471Conference ID number: 13756525 WebcastA live webcast and one-year archived replay of the call can be accessed on the Events page of the Investor Relations section of Gentherm's website at www.gentherm.com. A telephonic replay will be available approximatel

    10/8/25 4:30:00 PM ET
    $THRM
    Auto Parts:O.E.M.
    Consumer Discretionary

    McKesson Corporation Highlights Strategic Growth Strategies and Unveils Updated Long-term Financial Targets at Investor Day

    McKesson Corporation (NYSE:MCK) will host its 2025 Investor Day today, beginning at 9:30 AM ET. During the event, executive leadership will discuss the company's multi-year strategic priorities, growth strategies, and long-term business outlook. The Investor Day event will showcase how McKesson continues to accelerate long-term growth and deliver sustained value creation: Executing strategic priorities: Demonstrating significant progress, focusing on people and culture, strengthening North American Pharmaceutical distribution, modernizing and accelerating the portfolio, and expanding oncology, multispecialty, and biopharma services platforms. Advancing portfolio optimization: Provid

    9/23/25 8:00:00 AM ET
    $MCK
    Other Pharmaceuticals
    Health Care

    Medtronic reports first quarter fiscal 2026 financial results

    11th quarter in a row of mid-single digit organic revenue growth;Poised to accelerate growth GALWAY, Ireland, Aug. 19, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced financial results for its first quarter (Q1) of fiscal year 2026 (FY26), which ended July 25, 2025. Key Highlights Revenue of $8.6 billion, adjusted revenue of $8.5 billion, increased 8.4% as reported and 4.8% organicGAAP diluted EPS of $0.81 increased 1%; non-GAAP diluted EPS of $1.26 increased 2%Company raises FY26 EPS guidance; reiterates FY26 organic revenue growth guidanceCardiac Ablation Solutions revenue increased nearly 50%, incl

    8/19/25 6:45:00 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $AMZN
    $F
    $MCK
    $MDT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Amazon.com Inc.

    SC 13G/A - AMAZON COM INC (0001018724) (Subject)

    11/8/24 4:33:15 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Amazon.com Inc.

    SC 13G/A - AMAZON COM INC (0001018724) (Filed by)

    11/7/24 5:23:12 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form SC 13G/A filed by Medtronic plc. (Amendment)

    SC 13G/A - Medtronic plc (0001613103) (Subject)

    2/13/24 5:09:43 PM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care